siRNA goes after diseases of the bone
Open Access
- 20 October 2023
- journal article
- editorial
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 34, 102051
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Novel hybrid silicon-lipid nanoparticles deliver a siRNA to cure autosomal dominant osteopetrosis in mice. Implications for gene therapy in humansMolecular Therapy Nucleic Acids, 2023
- Engineered extracellular vesicles for bone therapyNano Today, 2022
- Current Aspects of siRNA Bioconjugate for In Vitro and In Vivo DeliveryMolecules, 2019
- Development of Bone Targeting DrugsInternational Journal of Molecular Sciences, 2017
- Therapeutic potential of chemically modified siRNA: Recent trendsChemical Biology & Drug Design, 2017
- siRNA Delivery Strategies: A Comprehensive Review of Recent DevelopmentsNanomaterials, 2017
- The chemical evolution of oligonucleotide therapies of clinical utilityNature Biotechnology, 2017
- Bone site-specific delivery of siRNAJournal of Biomedical Research, 2016